Description: Panelist discuss issues relating to new medical technologies and how these are going to affect the practice of medicine, the delivery of care, the costs of care, the insuring of care, claims handling, utilization, and cost management. From the Record of the Society of Actuaries, Vol. 25, No. 2.

Description: Impact of Technology on Health Care Delivery Systems - Chart 2

Description: This session describes the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. We will walk through the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. We will also walk through some sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: Chart 4 for Session 1030F: Impact of Technology on Health-Care Delivery Systems

Description: This session discussion is about state-mandated health benefits. Who should decide and who should pay? The basis of making decisions, effect on insurance rates, impact on self-insurance, legislative process and timing of savings. From Record of Society of Actuaries Vol. 16, No. 1.

Description: The discussion covers the implications of the current research of the Human Genome Project and explores the impact on public health. The presentation addresses how the research affects the life insurance industry. From the Record of the Society of Actuaries, Volume 27, No. 2, Session 4

Description: Participants discuss what steps can be taken to anticipate and mitigate the effect of the recession on health insurance costs. Those attending this session gain an understanding of the factors, including current economic conditions driving the pricing and design of health insurance products. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 78of.

Description: This is a discussion on the probable effects of medical advances on longevity. From Transactions of Society of Actuaries 1961, Vol. 13 Pt. 2

Description: HIV is still a big public health concern, but there are therapies available to prevent infection before and immediately after exposure. As legislatures and the USPSTF considers adding these therapies to the list of preventive care covered without cost share, actuaries will need to estimate the impact on their care cost. The presenters will share an actuarial tool kit to estimate the impact of covering PrEP and PEP for different populations. Examples are provided and discussion is welcome.

Description: This session discussion is about trends and proliferation of medical technology, what will be the impact on cost, what is on the horizon, strategies to contain the utilization of various procedures and technology. From Record of the Society of Actuaries Vol. 15, No. 1.